Match!
Johan Reutfors
Karolinska University Hospital
PsychiatryPsychologyCohort studyPopulationMedicine
71Publications
14H-index
757Citations
What is this?
Publications 73
Newest
#1Philip Brenner (KI: Karolinska Institutet)H-Index: 5
#2Lena Brandt (KI: Karolinska Institutet)H-Index: 38
Last. Johan Reutfors (KI: Karolinska Institutet)H-Index: 14
view all 6 authors...
BACKGROUND AND AIMS: Treatment-resistant depression (TRD), defined as inadequate treatment response after at least two adequate treatment trials, is common among patients initiating antidepressant treatment. Current or previous substance use disorders (SUD) are common among patients with depression and often lead to worse treatment outcomes. However, in clinical studies, SUD have not been found to increase the risk for TRD. The aim of this study was to investigate the association between SUD and...
Source
#1Johan Reutfors (Karolinska University Hospital)H-Index: 14
#2Philip Brenner (Karolinska University Hospital)H-Index: 5
Last. Lena Brandt (Karolinska University Hospital)H-Index: 38
view all 6 authors...
Introduction This post-authorization safety study (PASS) was a commitment to the European Medicines Agency.
Source
#1Eric Clapham (Uppsala University)H-Index: 2
#2Robert Bodén (Uppsala University)H-Index: 13
Last. Shahram Bahmanyar (Karolinska University Hospital)H-Index: 18
view all 8 authors...
Source
#1Rikke Wesselhoeft (University of Southern Denmark)H-Index: 3
#2Peter Bjødstrup Jensen (University of Southern Denmark)H-Index: 8
Last. Mette Bliddal (University of Southern Denmark)H-Index: 4
view all 9 authors...
Source
The risk of suicide is elevated among patients with treatment-resistant depression (TRD). Risk factors for suicide and suicide attempts among cases and controls with TRD were investigated using dat...
Source
#1Carl-Martin Pethrus (KI: Karolinska Institutet)H-Index: 1
#2Thomas Frisell (KI: Karolinska Institutet)H-Index: 21
Last. Martin Neovius (KI: Karolinska Institutet)H-Index: 46
view all 8 authors...
Source
#1Gang Li (Janssen Pharmaceutica)H-Index: 2
#2Daniel Fife (Janssen Pharmaceutica)H-Index: 16
Last. Allitia DiBernardo (Janssen Pharmaceutica)H-Index: 8
view all 9 authors...
Background Treatment-resistant depression (TRD) may represent a substantial proportion of major depressive disorder (MDD); however, the risk of mortality in TRD is still incompletely assessed.
1 CitationsSource
#1Eric Clapham (Uppsala University)H-Index: 2
#2Robert Bodén (Uppsala University)H-Index: 13
Last. Johan Reutfors (Karolinska University Hospital)H-Index: 14
view all 8 authors...
3 CitationsSource
#1Philip Brenner (KI: Karolinska Institutet)H-Index: 5
#2Lena Brandt (KI: Karolinska Institutet)H-Index: 38
Last. Johan Reutfors (KI: Karolinska Institutet)H-Index: 14
view all 6 authors...
Background and aims Treatment-resistant depression (TRD) is common among patients with major depressive disorder (MDD). MDD may increase the risk for developing substance use disorders (SUD). The a ...
Source
#1Mikkel Højlund (University of Southern Denmark)H-Index: 1
#2Anton PottegårdH-Index: 22
Last. Christoph U. Correll (Charité)H-Index: 2
view all 7 authors...
Source
12345678